Vikas Lifecare Share Price Target 2025, 2026, 2030, 2040, 2050
One of India’s most well-known chemical and specialized material companies is Vikas Lifecare Ltd. (NSE: VIKASLIFE). Aiming to capitalize on the increasing demand for specialized chemicals, the firm has set itself up to produce and trade various chemical goods.
This article will examine the fundamentals of Vikas Lifecare and market trends to forecast the share price projections for 2024–2050.
- 1 What is Vikas Lifecare Ltd NSE: VIKASLIFE?
- 2 Vikas Lifecare Share Price Target 2025
- 3 Vikas Lifecare Share Price Target 2026
- 4 Share Price Target 2027
- 5 Share Price Target 2028
- 6 Share Price Target 2029
- 7 Vikas Lifecare Share Price Target 2030
- 8 Share Price Target 2040
- 9 Share Price Target 2050
- 10 Should I Buy Vikas Lifecare Stock?
- 11 Vikas Lifecare Ltd Earning Results
- 12 Expert Forecasts on the Future of Vikas Lifecare Ltd.
- 13 Is Vikas Lifecare Stock Good to Buy? (Bull Case & Bear Case)
- 14 Conclusion
- 15 FAQs
What is Vikas Lifecare Ltd NSE: VIKASLIFE?
The Indian firm Vikas Lifecare Limited produces and sells chemicals, focusing on specialized chemicals. Since its inception in 1995, the company activities have expanded substantially, and it is now listed on both the Bombay Stock Exchange (BSE) and the National Stock Exchange (NSE). Among the many sectors that Vikas Lifecare serves are construction, agriculture, and packaging, all of which benefit from the company dedication to offering first-rate goods and services.
| Company Name | Vikas Lifecare Limited |
| Market Cap | ₹893.64 Cr (As of July 2024) |
| P/E Ratio (TTM) | 47.82 |
| P/B Ratio | 1.84 |
| Industry P/E | 62.52 |
| Debt to Equity Ratio | 0.07 |
| ROE | 3.83% |
| EPS (TTM) | ₹0.11 |
| Dividend Yield | 0.00% |
| 52 Week High | ₹8.00 |
| 52 Week Low | ₹3.00 |
| Book Value | ₹2.96 |
| Face Value | ₹1 |
| Official Website | Vikas Lifecare |
The primary drivers of this growth are the need for chemical goods across several industries, along with the company’s development goals and increased revenues. In 2025, its share price target would be ₹5.71, as per our analysis.
By our prediction, its share price would be between ₹1.82 and ₹5.71 in 2025.
| Year | Minimum Price (Rs) | Maximum Price (Rs) |
| 2025 | 1.82 | 5.71 |
| Month | Minimum Price (Rs) | Maximum Price (Rs) |
| January | 3.50 | 4.32 |
| February | 2.95 | 3.90 |
| March | 2.51 | 4.00 |
| April | 1.74 | 4.23 |
| May | 1.82 | 4.30 |
| June | 2.54 | 4.58 |
| July | 2.88 | 4.70 |
| August | 3.25 | 4.88 |
| September | 3.68 | 4.97 |
| October | 3.90 | 5.00 |
| November | 4.41 | 5.23 |
| December | 4.80 | 5.71 |
In 2026, its share price target would be ₹9.77, as per our analysis.
By our prediction, its share price would be between ₹5.30 to ₹9.77 in 2026.
| Year | Minimum Price (Rs) | Maximum Price (Rs) |
| 2026 | 5.30 | 9.77 |
| Month | Minimum Price (Rs) | Maximum Price (Rs) |
| January | 5.30 | 6.00 |
| February | 5.85 | 6.85 |
| March | 6.00 | 7.10 |
| April | 6.41 | 7.35 |
| May | 6.78 | 7.90 |
| June | 6.50 | 8.12 |
| July | 6.90 | 8.32 |
| August | 7.11 | 8.58 |
| September | 7.32 | 8.80 |
| October | 7.65 | 9.00 |
| November | 7.80 | 9.15 |
| December | 8.25 | 9.77 |
In 2027, its share price target would be ₹13.88, as per our analysis.
By our prediction, its share price would be between ₹8.90 to ₹13.88 in 2027.
| Year | Minimum Price (Rs) | Maximum Price (Rs) |
| 2027 | 8.90 | 13.88 |
In 2028, its share price target would be ₹18.34, as per our analysis.
By our prediction, its share price would be between ₹13.00 to ₹18.34 in 2028.
| Year | Minimum Price (Rs) | Maximum Price (Rs) |
| 2028 | 13.00 | 18.34 |
In 2029, its share price target would be ₹22.10, as per our analysis.
By our prediction, its share price would be between ₹17.20 to ₹22.10 in 2029.
| Year | Minimum Price (Rs) | Maximum Price (Rs) |
| 2029 | 17.20 | 22.10 |
The strategic positioning and product diversification of Vikas Lifecare, together with the expected expansion of the specialised chemicals sector, are the primary drivers of this substantial rise. In 2030, its share price target would be ₹26.52, as per our analysis.
By our prediction, its share price would be between ₹21.89 to ₹26.52 in 2030.
| Year | Minimum Price (Rs) | Maximum Price (Rs) |
| 2030 | 21.89 | 26.52 |
| Month | Minimum Price (Rs) | Maximum Price (Rs) |
| January | 21.89 | 22.78 |
| February | 22.32 | 23.00 |
| March | 22.57 | 23.21 |
| April | 22.75 | 23.75 |
| May | 22.90 | 24.09 |
| June | 23.42 | 24.47 |
| July | 23.84 | 24.75 |
| August | 24.00 | 24.90 |
| September | 24.25 | 25.20 |
| October | 24.78 | 26.00 |
| November | 25.20 | 26.14 |
| December | 25.74 | 26.52 |
This forecast considers Vikas Lifecare’s capacity to increase its market share and the sustained expansion of the chemicals industry. In 2040, its share price target would be ₹55.46, as per our analysis.
By our prediction, its share price would be between ₹50.44 to ₹55.46 in 2040.
| Year | Minimum Price (Rs) | Maximum Price (Rs) |
| 2040 | 50.44 | 55.46 |
| Month | Minimum Price (Rs) | Maximum Price (Rs) |
| January | 50.44 | 51.74 |
| February | 50.78 | 52.20 |
| March | 51.25 | 52.78 |
| April | 51.42 | 53.00 |
| May | 52.24 | 53.25 |
| June | 52.50 | 53.50 |
| July | 52.80 | 53.80 |
| August | 53.14 | 54.00 |
| September | 53.51 | 54.25 |
| October | 53.84 | 54.75 |
| November | 54.00 | 55.20 |
| December | 54.32 | 55.46 |
The chemicals business is expected to grow in the following years, along with the company’s persistent efforts in innovation and expanding into new markets. In 2050, its share price target would be ₹95.97, as per our analysis.
By our prediction, its share price would be between ₹90.56 to ₹95.97 in 2050.
| Year | Minimum Price (Rs) | Maximum Price (Rs) |
| 2050 | 90.56 | 95.97 |
| Month | Minimum Price (Rs) | Maximum Price (Rs) |
| January | 90.56 | 91.80 |
| February | 90.80 | 92.00 |
| March | 91.07 | 92.17 |
| April | 91.47 | 92.68 |
| May | 91.78 | 92.90 |
| June | 92.21 | 93.25 |
| July | 92.74 | 93.75 |
| August | 93.00 | 94.12 |
| September | 93.12 | 94.25 |
| October | 93.45 | 94.90 |
| November | 94.12 | 95.20 |
| December | 94.52 | 95.97 |
Should I Buy Vikas Lifecare Stock?
| Year | Minimum Price (Rs) | Maximum Price (Rs) |
| 2025 | 1.82 | 5.71 |
| 2026 | 5.30 | 9.77 |
| 2027 | 8.90 | 13.88 |
| 2028 | 13.00 | 18.34 |
| 2029 | 17.20 | 22.10 |
| 2030 | 20.89 | 26.52 |
| 2040 | 50.44 | 55.46 |
| 2050 | 90.56 | 95.97 |
Vikas Lifecare has been consistently successful in recent years, thanks to rising revenues and an emphasis on product diversification. The firm has been working hard to keep its finances in good shape to increase operational efficiency.
The specialty chemicals industry is poised for rising demand shortly, so investors should consider that when evaluating the company development prospects. Before making any investment choices, assessing the company financial health and current market circumstances is essential.
Vikas Lifecare Ltd Earning Results
Vikas Lifecare overall operational revenue for the fiscal year ending March 31, 2023, was ₹462.72 crore. A revenue increase of around 56.87% is another indicator of the company success in the chemicals industry. The company profitability is shown by its profits per share (EPS) of ₹0.11.
Expert Forecasts on the Future of Vikas Lifecare Ltd.
Vikas Lifecare strategic endeavours to increase its product offerings and market presence have analysts enthusiastic about the company future. Sales are predicted to rise due to the rising demand for specialized chemicals in sectors like agriculture and construction.
Is Vikas Lifecare Stock Good to Buy? (Bull Case & Bear Case)
Bull Case:
- There is a rising need for the specialized chemicals in which Vikas Lifecare works.
- The organization has shown Impressive revenue growth and plans to expand even more.
- As seen by a low debt-to-equity ratio, financial stability opens the door to investments that fuel growth.
Bear Case:
- The firm may be overvalued compared to its competitors due to its high P/E ratio.
- Chemical stock performance is susceptible to market and economic instability.
- Profitability and market share in the specialized chemicals industry might be impacted by competition.
Conclusion
Vikas Lifecare Limited is an attractive investment opportunity in the specialized chemicals industry. As the need for chemical goods continues to rise, the firm is poised to capitalize on its excellent market position, growth potential, and dedication to operational efficiency. Nevertheless, before making any investment choices, investors should carefully evaluate the associated risks and current market circumstances.
